Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Richard Singer who wrote (5672)	2/26/1998 12:43:00 PM
From: Sycamore	Read Replies (2) \| Respond to of 23519

Richard, Maybe, but the MHCM earning looks awful. Do you know why the stock is down over a point despite the good news? Any idea when the FDA approval will come? regards, sycamore

To: Richard Singer who wrote (5672)	2/26/1998 5:24:00 PM
From: Bill Fischofer	Read Replies (1) \| Respond to of 23519

"Competition" From the Yahoo profile on MCHM: "For the nine months ended 9/30/97, revenues fell 41% to $51 thousand. Net loss rose 13% to $2.8 million. Revenues reflect lower income from completed research contracts. Higher loss reflects the management and execution of ongoing clinical trials." Hardly competition worth mentioning. I've traded VVUS profitably twice since the December selloff and am looking for a reentry point for a longer-term hold. VVUS is clearly the best play on this seldom-mentioned aspect of the "graying of America".